Intra-Cellular Stock Valuation

ITCI
 Stock
  

USD 55.17  1.91  3.35%   

Do you want to know what the current value of Intra-Cellular Ther is today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Intra-Cellular Ther, is its stock price multiplied by the total number of shares outstanding, calculating Intra-Cellular Ther's enterprise value requires a different approach. It uses Intra-Cellular Ther's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
The current Enterprise Value is estimated to increase to about 4.5 B, while Free Cash Flow is projected to decrease to (266.7 M).
Intra-Cellular Ther retains a regular Real Value of $57.37 per share. The prevalent price of the firm is $55.17. At this time, the firm appears to be fairly valued. Our model calculates the value of Intra-Cellular Ther from evaluating the firm fundamentals such as Return On Equity of (52.87) %, return on asset of (29.58) %, and Shares Outstanding of 81.46 M as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage locking in undervalued assets and disposing overvalued assets since, at some point, asset prices and their ongoing real values will come together.
  
Refresh
Intra-Cellular Ther Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Intra-Cellular Ther's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Intra-Cellular Most Recent Valuation Data

Price Book
6.57
Price Sales
50.56
EBITDA
-304.6 M
Beta
1.27
Fiscal Year End
December
Industry
Drug Manufacturers-Specialty & Generic
Enterprise Value
4.5 B
Fairly Valued
Today 55.17
Please note that Intra-Cellular Ther's price fluctuation is very steady at this time. Calculation of the real value of Intra-Cellular Ther is based on 3 months time horizon. Increasing Intra-Cellular Ther's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Intra-Cellular Ther is useful when determining the fair value of the Intra-Cellular stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Intra-Cellular Ther. Since Intra-Cellular Ther is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Intra-Cellular Stock. However, Intra-Cellular Ther's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
57.37
Real Value
61.78
Upside
Estimating the potential upside or downside of Intra-Cellular Ther helps investors to forecast how Intra-Cellular stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Intra-Cellular Ther more accurately as focusing exclusively on Intra-Cellular Ther's fundamentals will not take into account other important factors:
Earnings
Estimates (5)
LowProjected EPSHigh
-3.53-3.46-3.32
Details
Hype
Prediction
LowEstimated ValueHigh
50.7055.1159.52
Details
Naive
Forecast
LowNext ValueHigh
57.1861.5865.99
Details
7 Analysts
Consensus
LowTarget PriceHigh
46.0060.0085.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Intra-Cellular Ther's intrinsic value based on its ongoing forecasts of Intra-Cellular Ther's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Intra-Cellular Ther's closest peers. When choosing an evaluation method for Intra-Cellular Ther, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Intra-Cellular Ther Investments

334.8 Million

Share

Intra-Cellular Valuation Drivers Correlation

Many accounts on the financial statements of Intra-Cellular Ther are highly interrelated and sometimes correlated. Consequently, when conducting Intra-Cellular's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Intra-Cellular
Click cells to compare fundamentals

Intra-Cellular Valuation Trend

Knowing Intra-Cellular Ther's actual value is paramount for traders to make sound investment determinations. Intra-Cellular Ther's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Intra-Cellular Ther's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Intra-Cellular Ther's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Intra-Cellular Market Cap

Intra-Cellular Ther is currently regarded as number one stock in market capitalization category among related companies. Market capitalization of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 3.8 Trillion. Intra-Cellular Ther adds roughly 4.72 Billion in market capitalization claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Capitalization  Valuation  Workforce  Revenue  Total debt

Intra-Cellular Ther Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Intra-Cellular Ther's current stock value. Our valuation model uses many indicators to compare Intra-Cellular Ther value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intra-Cellular Ther competition to find correlations between indicators driving Intra-Cellular Ther's intrinsic value. More Info.
Intra-Cellular Ther is currently regarded as number one stock in price to sales category among related companies. It is currently regarded as number one stock in price to earning category among related companies . The current Price to Earnings Ratio is estimated to decrease to -16.13. The current Earnings Before Interest Taxes and Depreciation Amortization EBITDA is estimated to decrease to about (291 M). Comparative valuation analysis is a catch-all model that can be used if you cannot value Intra-Cellular Ther by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Intra-Cellular Ther's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intra-Cellular Ther's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Intra-Cellular Ther's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Intra-Cellular Ther and how it compares across the competition.

About Intra-Cellular Ther Valuation

The equity valuation mechanism determines the current worth of Intra-Cellular Ther on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Intra-Cellular Ther. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Intra-Cellular Ther based exclusively on its fundamental and basic technical indicators. By analyzing Intra-Cellular Ther's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Intra-Cellular Ther's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Intra-Cellular Ther. We calculate exposure to Intra-Cellular Ther's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Intra-Cellular Ther's related companies.
Last ReportedProjected for 2022
Gross Profit75.8 M81.8 M
Profit Margin(3.39) (3.66) 
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. Intra-Cellular Ther operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 512 people.

Intra-Cellular Ther Quarterly Enterprise Value

5.66 Billion

Share

Intra-Cellular Ther Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Intra-Cellular Ther does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio8.11
Revenue Growth106.10%
Enterprise Value To Ebitda-15.25
Enterprise Value To Revenue51.91

Intra-Cellular Ther Current Valuation Indicators

Valuation refers to the process of determining the present value of Intra-Cellular Ther and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Intra-Cellular we look at many different elements of the entity such as Intra-Cellular's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Intra-Cellular Ther's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Intra-Cellular Ther's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Intra-Cellular Ther, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Intra-Cellular Ther's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Intra-Cellular Ther's worth.
Please see Risk vs Return Analysis. Note that the Intra-Cellular Ther information on this page should be used as a complementary analysis to other Intra-Cellular Ther's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Intra-Cellular Stock analysis

When running Intra-Cellular Ther price analysis, check to measure Intra-Cellular Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intra-Cellular Ther is operating at the current time. Most of Intra-Cellular Ther's value examination focuses on studying past and present price action to predict the probability of Intra-Cellular Ther's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intra-Cellular Ther's price. Additionally, you may evaluate how the addition of Intra-Cellular Ther to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Is Intra-Cellular Ther's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intra-Cellular Ther. If investors know Intra-Cellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intra-Cellular Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
5.2 B
Quarterly Revenue Growth YOY
1.2
Return On Assets
-0.25
Return On Equity
-0.43
The market value of Intra-Cellular Ther is measured differently than its book value, which is the value of Intra-Cellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intra-Cellular Ther's value that differs from its market value or its book value, called intrinsic value, which is Intra-Cellular Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intra-Cellular Ther's market value can be influenced by many factors that don't directly affect Intra-Cellular Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intra-Cellular Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine Intra-Cellular Ther value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intra-Cellular Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.